Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

JMC Partners strengthens senior team

Appoints Andrew Bonser as director, policy andprojects

- PMLiVE

Grunenthal and AcelRx’s Zalviso approved in EU

Provides new treatment for post-operative pain

- PMLiVE

Pfizer launches first self-injectable contraceptive in UK

New option for female contraception hits UK

- PMLiVE

Amgen and Allergan close on Avastin biosimilar filing

ABP 215 matches reference drug in study

Tackling biosimilars – how to handle the threat to Pharma brands

Strategy Consultant Mark Assenti outlines three key points for developing a strategy to tackle the threat to Pharma brands from biosimilars.

Blue Latitude Health

- PMLiVE

Astellas selects new CFO for its EMEA operations

Japanesefirm also appoints newmanager for its US corporate affairs team

- PMLiVE

ViiV boosted by positive phase III results for HIV drug Triumeq

Data reaffirms benefitsof drug in comparison to current antiretroviral medications 

- PMLiVE

Proteus: Digital medicines set to transform healthcare

Tells PM Society event that pharma and health systems have reached a pivot point

- PMLiVE

FDA clears Taiho’s oral colorectal cancer drug

Regulatory nod for Lonsurf gives patients additional treatment options

- PMLiVE

DigitasLBi appoints Alvaro Cabrera as chief strategy officer

He joins the agency from OgilvyOneNew York

- PMLiVE

Roche says Esbriet boosts survival in pulmonary fibrosis

Positive results due to be presented at European Respiratory Society 

Is Technology Harming Your Brain?

Is technology harming your brain? Saycomms healthcare PR team confronts different opinions on how technology affects memories and attention span.

Say Communications

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links